Literature DB >> 33709463

Loss of Tmem106b leads to cerebellum Purkinje cell death and motor deficits.

Rosa Rademakers1,2,3, Alexandra M Nicholson1, Yingxue Ren4, Shunsuke Koga1, Hung Phuoc Nguyen1, Mieu Brooks1, Wenhui Qiao1, Zachary S Quicksall4, Billie Matchett1, Ralph B Perkerson1, Aishe Kurti1, Monica Castanedes-Casey1, Virginia Phillips1, Ariston L Librero1, Cristhoper H Fernandez De Castro1, Matthew C Baker1, Shanu F Roemer1, Melissa E Murray1, Yan Asmann4, John D Fryer1, Guojun Bu1, Dennis W Dickson1, Xiaolai Zhou1,5.   

Abstract

TMEM106B has been recently implicated in multiple neurodegenerative diseases. Here, Rademakers et al. report a late-onset cerebellar Purkinje cell loss and progressive decline in motor function and gait deficits in a conventional Tmem106b-/- mouse model. By using high-power microscopy and bulk RNA sequencing, the authors further identify lysosomal and immune dysfunction as potential underlying mechanisms of the Purkinje cell loss.
© 2021 The Authors. Brain Pathology published by John Wiley & Sons Ltd on behalf of International Society of Neuropathology.

Entities:  

Year:  2021        PMID: 33709463     DOI: 10.1111/bpa.12945

Source DB:  PubMed          Journal:  Brain Pathol        ISSN: 1015-6305            Impact factor:   6.508


  2 in total

1.  Homotypic fibrillization of TMEM106B across diverse neurodegenerative diseases.

Authors:  Andrew Chang; Xinyu Xiang; Jing Wang; Carolyn Lee; Tamta Arakhamia; Marija Simjanoska; Chi Wang; Yari Carlomagno; Guoan Zhang; Shikhar Dhingra; Manon Thierry; Jolien Perneel; Bavo Heeman; Lauren M Forgrave; Michael DeTure; Mari L DeMarco; Casey N Cook; Rosa Rademakers; Dennis W Dickson; Leonard Petrucelli; Michael H B Stowell; Ian R A Mackenzie; Anthony W P Fitzpatrick
Journal:  Cell       Date:  2022-03-04       Impact factor: 66.850

2.  TMEM106B deficiency impairs cerebellar myelination and synaptic integrity with Purkinje cell loss.

Authors:  Tuancheng Feng; Lin Luan; Isabel Iscol Katz; Mohammed Ullah; Vivianna M Van Deerlin; John Q Trojanowski; Edward B Lee; Fenghua Hu
Journal:  Acta Neuropathol Commun       Date:  2022-03-14       Impact factor: 7.801

  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.